Allergan Deal Clouds Rightful Activist Role In Hostile M&A
A $66 billion counterbid for Allergan Inc. thwarted a hostile takeover push by Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman, but while it resolved speculation over the target's future,...To view the full article, register now.
Already a subscriber? Click here to view full article